Glycerol is a key metabolite involved in various physiological processes, including lipid metabolism, gluconeogenesis, and energy homeostasis.
Its levels, along with those of fatty acids (FAs), have been recognized as potential biomarkers for metabolic disorders, particularly hyperglycemia and type 2 diabetes.
Glycerol is a three-carbon backbone molecule for triglycerides (fats/lipids) that are stored in adipose tissue and skeletal muscle. During lipolysis (breakdown of triglycerides), glycerol is released into circulation along with free fatty acids.
When it’s released in circulation via lipolysis, glycerol can then be metabolized in the human body via two main pathways: gluconeogenesis, where it is converted to glucose, and glycolysis, where it is converted to lactate.
Glycerol plays a pivotal role in various metabolic pathways, contributing to energy homeostasis via gluconeogenesis or glycolysis.
One study showed that oral administration of glycerol led to higher serum glucose levels, indicating increased gluconeogenesis, while intravenous administration resulted in higher serum lactate levels, suggesting enhanced direct conversion of glycerol to lactate. [9.]
These findings highlight that glycerol metabolism varies depending on its route of entry into the body, with the liver playing a key role in converting orally ingested glycerol to glucose, and non-hepatic tissues more actively converting intravenously administered glycerol to lactate.
This differential metabolism has implications for understanding how glycerol impacts blood sugar and lactate levels, particularly in metabolic conditions such as diabetes.
Gluconeogenesis is the metabolic pathway that synthesizes glucose from non-carbohydrate precursors like lactate, amino acids, and glycerol, especially in the liver.
Glycerol can directly enter the gluconeogenic pathway in hepatocytes by being converted to glycerol-3-phosphate by glycerol kinase, and then entering as an intermediate of glycolysis/gluconeogenesis.
In fasting conditions, glycerol is a major source of new carbon atoms incorporated into newly produced glucose molecules through gluconeogenesis, contributing over 50% of the net carbons. [10., 12.]
The liver and kidney, which have high glycerol kinase expression, can directly utilize glycerol for gluconeogenesis, while other tissues like intestines can convert glycerol to lactate, which then enters the gluconeogenic pathway.
In type 2 diabetes, increased lipolysis leads to higher circulating glycerol levels, potentially making glycerol an even more significant gluconeogenic substrate contributing to hyperglycemia.
Glycolysis is defined as the metabolic pathway that breaks down glucose or glycerol into pyruvic or lactic acid, releasing energy in the form of ATP and NADH.
Glycerol itself cannot directly enter the glycolysis pathway. It first needs to be converted into glycerol-3-phosphate by the enzyme glycerol kinase.
Glycerol-3-phosphate is then oxidized to dihydroxyacetone phosphate (DHAP) by the enzyme glycerol-3-phosphate dehydrogenase. DHAP then enters at the 5th step of the glycolytic pathway, ultimately ending in ATP production.
Glycerol is a fundamental component of triglycerides, the main form of stored fat and energy reserves, and phospholipids, which are essential for cellular membrane structure and cellular signalling. The synthesis of these lipids involves the esterification of glycerol with fatty acids, a process catalyzed by various enzymes.
The glycerol-3-phosphate (G3P) pathway is the main pathway in lipogenesis, contributing over 90% of total triglyceride synthesis.
Glycerol is first converted into glycerol-3-phosphate. Then, a long-chain acyl-CoA is attached to G3P, catalyzed by mitochondrial and microsomal GPAT (glycerol-3-phosphate acyltransferase) enzymes.
Diacylglycerol is then formed, and a third fatty acid is attached, ending ultimately in triglyceride synthesis.
In the liver, the newly synthesized triglycerides can be incorporated into very-low-density lipoproteins (VLDL) for export, or stored in cytosolic lipid droplets. Lipogenesis also occurs in adipocytes and in the small intestine.
Newly synthesized TG molecules are directed from the ER lipid bilayer to form cytosolic LDs (lipid droplets).
Lipolysis is the metabolic pathway through which triglycerides (fats) stored in lipid droplets within cells are broken down or hydrolyzed into free fatty acids and glycerol.
During periods of energy demand, such as fasting or exercise, triacylglycerols stored in adipose tissue undergo lipolysis, resulting in the release of glycerol and free fatty acids (FFAs) into the bloodstream.
This process is mediated by lipases and hormones, including glucagon and catecholamines.
The released free fatty acids can then be used for energy production, membrane synthesis or as signaling molecules, while glycerol can enter gluconeogenesis pathways
Emerging evidence suggests that glycerol levels, in conjunction with other metabolic markers, may serve as valuable indicators of metabolic disorders, particularly hyperglycemia and type 2 diabetes.
Several studies have demonstrated a positive correlation between elevated glycerol levels and the presence of hyperglycemia and type 2 diabetes.
Elevated triglycerides are often seen early in hyperglycemia as well in type 2 diabetes, and lipolysis causes the release of glycerol in the bloodstream. Glycerol promotes gluconeogenesis, which raises blood sugar levels.
This association between elevated glycerol, hyperglycemia and type 2 diabetes is attributed to increased triglyceride levels, the dysregulation of lipid metabolism and insulin resistance, which are hallmarks of these metabolic disorders.
Glycerol levels have been found to be positively associated with both fasting and postprandial glucose levels. This relationship highlights the potential utility of glycerol as a biomarker for monitoring glucose homeostasis and identifying individuals at risk for developing metabolic disorders.
Glycerol blood tests can measure glycerol levels in blood to diagnose hyperglycerolemia.
Measuring glycogen as a stand-alone biomarker is often done through specialized testing processes using blood or other samples. One example is the Glycerol-Glo™ Assay, a widely used method for quantifying glycerol levels in biological samples.
The Glycerol-Glo™ Assay is one method that measures glycerol in a reaction that links the production of NADH to the activation of a proluciferin, which then produces light with luciferase. Glycerol kinase and glycerol-3-phosphate dehydrogenase are used to generate NADH.
Bound glycerol can also be determined by assessing triglyceride levels; there is one molecule of glycerol per triglyceride in the bloodstream, although this does not describe the amount of free glycerol present in the bloodstream.
Free fatty acids (FFAs) are released during lipolysis, along with glycerol.
A free fatty acid (FFA) blood test, also known as a nonesterified fatty acid (NEFA) assay, measures the level of nonesterified fatty acids in blood plasma. This test can help diagnose and manage certain metabolic disorders and diseases, and evaluate potential causes of hyperlipoproteinemia.
It can also be used to assess nutritional status and evaluate patients with hypoglycemia.
Increased levels of glycerol, free fatty acids (FFAs), monounsaturated fatty acids (MUFAs), saturated fatty acids (SFAs), and certain fatty acid species, such as n-7 and n-9, have been associated with an increased risk of metabolic disorders, including hyperglycemia and type 2 diabetes.
In contrast to other fatty acid species, n-6 fatty acids, particularly linoleic acid, have been suggested to exert a protective effect against metabolic disorders.
Higher levels of these fatty acids have been linked to improved insulin sensitivity and a reduced risk of developing metabolic complications.
The FAQ section addresses common questions and concerns about glycerol, providing clear and concise answers for better understanding.
Glycerol, also known as glycerin, is a simple polyol compound that is a colorless, odorless, and sweet-tasting liquid. It is a trihydroxy alcohol, meaning it has three hydroxyl (OH) groups, making it highly soluble in water.
In the human body, glycerol is the backbone of triglyceride molecules, which are the major lipid storage form in the body.
Glycerol is made of three carbon atoms, eight hydrogen atoms, and three hydroxyl groups (C3H8O3). It is derived from both natural sources, such as animal fats and vegetable oils, and synthetic processes.
Glycerol has a wide range of uses across various industries. It is commonly used as a humectant, solvent, and sweetener in food products.
In pharmaceuticals and cosmetics, it acts as a moisturizer and emollient. Additionally, glycerol is used in the production of soaps, lotions, and as an antifreeze in industrial applications.
In pre-workout supplements, glycerol is used for its hydrating properties. It helps to draw water into the muscles and bloodstream, enhancing hydration and potentially improving exercise performance and endurance.
This increased water retention can also lead to better muscle function during workouts.
Yes, glycerol is generally recognized as safe (GRAS) by the FDA when used in appropriate amounts. However, excessive consumption can lead to side effects such as gastrointestinal discomfort, including bloating and diarrhea.
Glycerol is commonly used in skincare products due to its moisturizing and hydrating properties. It helps to attract water to the skin, keeping it soft, smooth, and hydrated. It is often found in lotions, creams, and other topical products.
Yes, glycerol is used in food as a sweetener, humectant, and preservative. It helps to retain moisture in food products, improve texture, and extend shelf life. It is commonly found in baked goods, confections, and beverages.
While glycerol is generally safe, some people may experience side effects such as headaches, dizziness, nausea, and gastrointestinal issues like diarrhea or bloating, especially when consumed in large amounts. It is important to use glycerol in moderation and follow recommended dosages.
Glycerol is absorbed in the small intestine and distributed throughout the body's tissues. It plays a role in various metabolic processes, including energy production and the maintenance of cell membrane integrity. It also helps to maintain proper hydration by drawing water into tissues.
Glycerol can be vegan, depending on its source. Vegetable glycerol, derived from plant oils such as palm, soy, or coconut, is vegan. However, glycerol derived from animal fats is not.
It is important to check product labels or verify with manufacturers if vegan certification is required.
Click here to compare testing options and order testing for metabolic health assessment.
[1.] Alves-Bezerra M, Cohen DE. Triglyceride Metabolism in the Liver. Compr Physiol. 2017 Dec 12;8(1):1-8. doi: 10.1002/cphy.c170012. PMID: 29357123; PMCID: PMC6376873.
[2.] Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res. 2011 Jan;50(1):14-27. doi: 10.1016/j.plipres.2010.10.004. Epub 2010 Nov 16. PMID: 21087632; PMCID: PMC3031774.
[3.] Lumen Learning. Lipid Metabolism | Anatomy and Physiology II. Lumenlearning.com. Published 2020. https://courses.lumenlearning.com/suny-ap2/chapter/lipid-metabolism/
[4.] Mahendran Y, Cederberg H, Vangipurapu J, Kangas AJ, Soininen P, Kuusisto J, Uusitupa M, Ala-Korpela M, Laakso M. Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men. Diabetes Care. 2013 Nov;36(11):3732-8. doi: 10.2337/dc13-0800. Epub 2013 Sep 11. PMID: 24026559; PMCID: PMC3816902.
[5.] NEFA - Overview: Free Fatty Acids, Total, Serum. @mayocliniclabs. Published 2021. Accessed June 13, 2024. https://www.mayocliniclabs.com/test-catalog/overview/606892#Overview
[6.] Patlar S, Yalçin H, Boyali E. The effect of glycerol supplements on aerobic and anaerobic performance of athletes and sedentary subjects. J Hum Kinet. 2012 Oct;34:69-79. doi: 10.2478/v10078-012-0065-x. Epub 2012 Oct 23. PMID: 23487412; PMCID: PMC3590833.
[7.] Rotondo F, Ho-Palma AC, Remesar X, Fernández-López JA, Romero MDM, Alemany M. Glycerol is synthesized and secreted by adipocytes to dispose of excess glucose, via glycerogenesis and increased acyl-glycerol turnover. Sci Rep. 2017 Aug 21;7(1):8983. doi: 10.1038/s41598-017-09450-4. PMID: 28827624; PMCID: PMC5567128.
[8.] Rowland, L.A., Guilherme, A., Henriques, F. et al. De novo lipogenesis fuels adipocyte autophagosome and lysosome membrane dynamics. Nat Commun 14, 1362 (2023). https://doi.org/10.1038/s41467-023-37016-8
[9.] Shah A, Wang Y, Wondisford FE. Differential Metabolism of Glycerol Based on Oral versus Intravenous Administration in Humans. Metabolites. 2022 Sep 22;12(10):890. doi: 10.3390/metabo12100890. PMID: 36295792; PMCID: PMC9611849.
[10.] Shah AM, Wondisford FE. Tracking the carbons supplying gluconeogenesis. J Biol Chem. 2020 Oct 16;295(42):14419-14429. doi: 10.1074/jbc.REV120.012758. Epub 2020 Aug 13. PMID: 32817317; PMCID: PMC7573258.
[11.] van Rosendal SP, Osborne MA, Fassett RG, Coombes JS. Physiological and performance effects of glycerol hyperhydration and rehydration. Nutr Rev. 2009 Dec;67(12):690-705. doi: 10.1111/j.1753-4887.2009.00254.x. PMID: 19941615.
[12.] Wang Y, Kwon H, Su X, Wondisford FE. Glycerol not lactate is the major net carbon source for gluconeogenesis in mice during both short and prolonged fasting. Mol Metab. 2020 Jan;31:36-44. doi: 10.1016/j.molmet.2019.11.005. Epub 2019 Nov 9. PMID: 31918920; PMCID: PMC6881678.
[13.] Xu H. Glycerol metabolism regulates gluconeogenesis. rucore.libraries.rutgers.edu. Published 2023. Accessed June 12, 2024. https://rucore.libraries.rutgers.edu/rutgers-lib/70994/
[14.] Yuasa H, Hamamoto K, Dogu SY, Marutani T, Nakajima A, Kato T, Hayashi Y, Inoue K, Watanabe J. Saturable absorption of glycerol in the rat intestine. Biol Pharm Bull. 2003 Nov;26(11):1633-6. doi: 10.1248/bpb.26.1633. PMID: 14600418.
[15.] Zheng D, Dou J, Liu G, et al. Association Between Triglyceride Level and Glycemic Control Among Insulin-Treated Patients With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2018;104(4):1211-1220. doi:https://doi.org/10.1210/jc.2018-01656